Search for: "Wells v. Ortho Pharmaceutical Corp" Results 21 - 40 of 104
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Aug 2015, 10:56 am
  This principle could certainly apply to innovator manufacturers as well in circumstances where the manufacturer could not make the proposed changes without government assistance.Mutual Pharmaceutical Co., Inc. v. [read post]
9 Apr 2015, 5:00 am
Medicis Pharmaceutical Corp., 342 P.3d 847 (Ariz App. 2015), once, here. [read post]
31 Dec 2014, 5:00 am
                  Ortho-McNeil-Janssen Pharmaceutical, Inc. v. [read post]
17 Dec 2014, 12:38 pm by Schachtman
Ortho Pharmaceutical Corp., 788 F. 2d 741, 744–745 (11th Cir. 1986), was also cited in support of the suggestion that statistical significance was not necessary, but in Wells, the plaintiffs’ expert witnesses actually relied upon studies that claimed at least nominal statistical significance. [read post]
27 Jul 2014, 9:03 am by Schachtman
  Lawyers without scientific training or aptitude are not likely to serve clients, whether plaintiffs or defendants, well in the post-Daubert litigation world. [read post]
18 Jul 2014, 11:55 am
 It may well be foreseeable that competitors will mimic a product design or label. [read post]
23 Jun 2014, 12:57 pm by Schachtman
Ortho Pharmaceutical Corp., 788 F. 2d 741, 744–745 (11th Cir. 1986). [read post]
19 Sep 2013, 9:53 am by Bexis
  [The expert] testified as to the well-recognized unreliability . [read post]
5 Jul 2013, 5:00 am by Bexis
Ortho Pharmaceutical Corp., 661 N.E.2d 352, 355 (Ill. 1996). [read post]